课题基金 / 基金详情

MONITORING LYMPHOCYTES PHENOTYPE DURING T101/ITRIUM THERAPY

MONITORING LYMPHOCYTES PHENOTYPE DURING T101/ITRIUM THERAPY
T101/ITRIUM 治疗期间监测淋巴细胞表型
批准号:
3874352
负责人:
T A FLEISHER
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

T A FLEISHER的其他基金

相关文献

中文摘要
翻译
患有T细胞和B细胞淋巴网状细胞恶性肿瘤的患者, 细胞表面抗原CDS将在单克隆抗体之前进行评价 治疗,以确认报告的肿瘤细胞结果。外周血 然后通过流式细胞术对淋巴样细胞进行免疫表型分析, 将在给药前和给药后立即监测表型 单克隆抗体治疗应特别注意 淋巴样群体分布和CDS的状态。病人 然后每天学习一周,下个月每周学习一次, 在此之后定期。
英文摘要
Patients with T cell and B cell lymphoreticular malignancies bearing the cell surface antigen CDS will be evaluated prior to monoclonal antibody therapy to confirm the reported tumor cell findings. The peripheral blood lymphoid cells will then be immunophenotyped by flow cytometry and the phenotype will be monitored prior to and at intervals immediately post monoclonal antibody therapy. Particular attention to be paid to the lymphoid population distribution and the status of CDS. The patients are then studied daily for one week, weekly for the next month, and then periodically after that time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INVESTIGATION OF THE LYMPHOCYTE PHENOTYPES IN NORMAL INDIVIDUALS
  • 批准号:
    3963193
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    T A FLEISHER
  • 依托单位:
LYMPHOCYTE PHENOTYPES IN PATIENTS WITH COMMON VARIABLE HYPOGRAMMAGLOBULINEMIA
  • 批准号:
    3963192
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    T A FLEISHER
  • 依托单位:
ASSESSMENT OF PERIPHERAL BLOOD EOSINOPHILS
  • 批准号:
    6161566
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    T A FLEISHER
  • 依托单位:
MONITORING LYMPHOCYTES PHENOTYPE DURING T101/ITRIUM THERAPY
  • 批准号:
    3916534
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    T A FLEISHER
  • 依托单位: